Vitalhub (TSE:VHI) Upgraded at TD Securities

TD Securities upgraded shares of Vitalhub (TSE:VHIFree Report) to a strong-buy rating in a research note published on Monday morning,Zacks.com reports.

Separately, Cormark boosted their target price on shares of Vitalhub from C$9.50 to C$10.50 and gave the company a “buy” rating in a research report on Wednesday, October 2nd.

View Our Latest Analysis on Vitalhub

Vitalhub Trading Up 0.6 %

TSE:VHI opened at C$10.86 on Monday. The stock has a 50 day simple moving average of C$9.67 and a 200 day simple moving average of C$8.31. Vitalhub has a 1-year low of C$3.81 and a 1-year high of C$11.50. The stock has a market cap of C$552.23 million, a P/E ratio of 99.00, a PEG ratio of 1.18 and a beta of 1.26.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

Further Reading

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.